Mainz Biomed N.V. (MYNZ) at a glance

Mainz Biomed N.V. (MYNZ) is a micro-cap Healthcare company. It trades at $1.54, with a 72.6% profit margin and revenue decline of 44.9%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Momentum (32/100). It is a relatively defensive holding with below-market volatility.

Price

$1.54

Market cap

$26.5M

P/E ratio

n/a

Dividend yield

None

Beta

0.32

52-week range

$0.30 to $4.93